1. Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies
- Author
-
Xiaoshuai Zhou, Qiufeng Zhang, Dongying Wang, Zhiyi Xiang, Jiale Ruan, and Linlin Tang
- Subjects
inflammatory bowel diseases ,hematologic malignancies ,meta-analysis ,leukemia ,lymphoma ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/Aims: Inflammatory bowel disease (IBD) may contribute to the development of hematologic malignancies. In this study, the potential relationship between IBD and hematologic malignancies was investigated. Methods: We searched the PubMed, Web of Science, Embase, and Cochrane Library databases for all cohort studies comparing the incidence of hematologic malignancies in non-IBD populations with that in IBD patients, and we extracted relevant data from January 2000 to June 2023 for meta-analysis. Results: Twenty cohort studies involving 756,377 participants were included in this study. The results showed that compared with the non-IBD cohort, the incidence of hematologic malignancies in the IBD cohort was higher (standardized incidence ratio [SIR]=3.05, p
- Published
- 2024
- Full Text
- View/download PDF